Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)

R. C. Coombes; Sacha Howell; Simon R. Lord; Laura Kenny; Janine Mansi; Zahi Mitri; Carlo Palmieri; Linnea I. Chap; Paul Richards; William Gradishar; Sagar Sardesai; Jason Melear; Joyce O’Shaughnessy; Patrick Ward; Pavani Chalasani; Tobias Arkenau; Richard D. Baird; Rinath Jeselsohn; Simak Ali; Glen Clack; Ashwani Bahl; Stuart McIntosh; Matthew G. Krebs

doi:10.1038/s41467-023-40561-x

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)

R. C. Coombes
, Sacha Howell
, Simon R. Lord
, Laura Kenny
, Janine Mansi
, Zahi Mitri
, Carlo Palmieri
, Linnea I. Chap
, Paul Richards
, William Gradishar
, Sagar Sardesai
, Jason Melear
, Joyce O’Shaughnessy
, Patrick Ward
, Pavani Chalasani
, Tobias Arkenau
, Richard D. Baird
, Rinath Jeselsohn
, Simak Ali
, Glen Clack

Ashwani Bahl, Stuart McIntosh, Matthew G. Krebs

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Correction to: Nature Communications, published online 24 July 2023 In this article the author name R. C. Coombes was incorrectly written as R. Charles Coombes. The original article has been corrected.

Original language	English (US)
Article number	4741
Journal	Nature communications
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41467-023-40561-x
State	Published - Dec 2023

ASJC Scopus subject areas

General Chemistry
General Biochemistry, Genetics and Molecular Biology
General
General Physics and Astronomy

Access to Document

10.1038/s41467-023-40561-x

Fingerprint

Dive into the research topics of 'Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)'. Together they form a unique fingerprint.

Cite this

Coombes, R. C., Howell, S., Lord, S. R., Kenny, L., Mansi, J., Mitri, Z., Palmieri, C., Chap, L. I., Richards, P., Gradishar, W., Sardesai, S., Melear, J., O’Shaughnessy, J., Ward, P., Chalasani, P., Arkenau, T., Baird, R. D., Jeselsohn, R., Ali, S., ... Krebs, M. G. (2023). Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y). Nature communications, 14(1), Article 4741. https://doi.org/10.1038/s41467-023-40561-x

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y). / Coombes, R. C.; Howell, Sacha; Lord, Simon R. et al.
In: Nature communications, Vol. 14, No. 1, 4741, 12.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Coombes, RC, Howell, S, Lord, SR, Kenny, L, Mansi, J, Mitri, Z, Palmieri, C, Chap, LI, Richards, P, Gradishar, W, Sardesai, S, Melear, J, O’Shaughnessy, J, Ward, P, Chalasani, P, Arkenau, T, Baird, RD, Jeselsohn, R, Ali, S, Clack, G, Bahl, A, McIntosh, S & Krebs, MG 2023, 'Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)', Nature communications, vol. 14, no. 1, 4741. https://doi.org/10.1038/s41467-023-40561-x

@article{b33e362520fd4afa9049a581fb272691,

title = "Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)",

abstract = "Correction to: Nature Communications, published online 24 July 2023 In this article the author name R. C. Coombes was incorrectly written as R. Charles Coombes. The original article has been corrected.",

author = "Coombes, \{R. C.\} and Sacha Howell and Lord, \{Simon R.\} and Laura Kenny and Janine Mansi and Zahi Mitri and Carlo Palmieri and Chap, \{Linnea I.\} and Paul Richards and William Gradishar and Sagar Sardesai and Jason Melear and Joyce O{\textquoteright}Shaughnessy and Patrick Ward and Pavani Chalasani and Tobias Arkenau and Baird, \{Richard D.\} and Rinath Jeselsohn and Simak Ali and Glen Clack and Ashwani Bahl and Stuart McIntosh and Krebs, \{Matthew G.\}",

note = "Publisher Copyright: {\textcopyright} 2023, Springer Nature Limited.",

year = "2023",

month = dec,

doi = "10.1038/s41467-023-40561-x",

language = "English (US)",

volume = "14",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)

AU - Coombes, R. C.

AU - Howell, Sacha

AU - Lord, Simon R.

AU - Kenny, Laura

AU - Mansi, Janine

AU - Mitri, Zahi

AU - Palmieri, Carlo

AU - Chap, Linnea I.

AU - Richards, Paul

AU - Gradishar, William

AU - Sardesai, Sagar

AU - Melear, Jason

AU - O’Shaughnessy, Joyce

AU - Ward, Patrick

AU - Chalasani, Pavani

AU - Arkenau, Tobias

AU - Baird, Richard D.

AU - Jeselsohn, Rinath

AU - Ali, Simak

AU - Clack, Glen

AU - Bahl, Ashwani

AU - McIntosh, Stuart

AU - Krebs, Matthew G.

PY - 2023/12

Y1 - 2023/12

N2 - Correction to: Nature Communications, published online 24 July 2023 In this article the author name R. C. Coombes was incorrectly written as R. Charles Coombes. The original article has been corrected.

AB - Correction to: Nature Communications, published online 24 July 2023 In this article the author name R. C. Coombes was incorrectly written as R. Charles Coombes. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85166784858

UR - https://www.scopus.com/pages/publications/85166784858#tab=citedBy

U2 - 10.1038/s41467-023-40561-x

DO - 10.1038/s41467-023-40561-x

M3 - Comment/debate

C2 - 37550302

AN - SCOPUS:85166784858

SN - 2041-1723

VL - 14

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 4741

ER -

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this